NGNE Latest Headlines

3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026

at www.tipranks.com (Thu, 9-Apr 12:37 PM)

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL)

at www.tipranks.com (Tue, 7-Apr 1:20 PM)

FDA Breakthrough Therapy Designation for NGN-401 Puts Neurogene at the Forefront of Rett Syndrome Innovation

Market Chameleon (Fri, 27-Feb 11:15 AM)

NGN-401 Granted FDA Breakthrough Therapy Status on Promising Rett Syndrome Trial Results

Market Chameleon (Fri, 27-Feb 7:06 AM)